According to a very interesting article by a retired physician with wide experience, initial batches of many drugs are problematic. He wrote: "the number of patients placed on the new pharmaceutical is usually many times the number of research participants. As a result, bad reactions, including deaths, from the new product that were not …
According to a very interesting article by a retired physician with wide experience, initial batches of many drugs are problematic. He wrote: "the number of patients placed on the new pharmaceutical is usually many times the number of research participants. As a result, bad reactions, including deaths, from the new product that were not seen during the research can emerge." Caveat emptor.
According to a very interesting article by a retired physician with wide experience, initial batches of many drugs are problematic. He wrote: "the number of patients placed on the new pharmaceutical is usually many times the number of research participants. As a result, bad reactions, including deaths, from the new product that were not seen during the research can emerge." Caveat emptor.
brownstone.org/articles/a-retired-physicians-view-of-american-healthcare/